SARS-CoV-2
Conditions
Interventions
None listed
Sponsors
National Center for Global Health and Medicine
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: (1) For compliance on the ethical aspects of the study, only individuals who willingly and voluntarily participate are selected. In addition, the wide range of age population is sufficient to address the objectives of the study. (2) Based on the presumption that seven years old is the minimum age that can comprehend any explanation about the study (3) The Rapid Antigen Test in this study is designed to detect SARS-CoV-2 virus which can be useful in the diagnosis of the infection
Exclusion criteria
Exclusion criteria: (1) Swab specimens is difficult to collect from individuals who use illegal drugs due to a possible nasal mucosal injury. (2) Detection of virus may be difficult to collect if symptoms have elapsed 5 days from the onset (3) Any incompatible factors may affect the study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Primary endpoint: The agreement rate between the test results of RT-PCR test and the Rapid Antigen Test. | — |
Secondary
| Measure | Time frame |
|---|---|
| Secondary endpoint: The agreement rate between the Rapid Antigen Test and RT-PCR test in specimens collected at different times after onset and the agreement rate of test results in two different types of specimen. | — |
Countries
Asia(except Japan)
Contacts
Public ContactMaria Ruriko Umano
National Center for Global Health and Medicine Department of International Trials
Outcome results
None listed